PubMed · 2013 · 258 citations · 12 references
Systemic DiseasesDisease ProgressionNeurological DisorderImmunologyImmune SystemClinical EpidemiologyNeurologyPublic HealthNeuropathologyNeuroimmunologyAutoimmune DiseaseSystemic SclerodermaNeuroepidemiologyAutoimmunityImmunologic DiseaseSclerodermaEpidemiologyMultiple SclerosisCentral Nervous SystemMedicine
Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system that affects approximately 400,000 people in the United States. The etiology of MS is unknown, but it is likely the result of a complex interaction between genetic and environmental factors and the immune system. The clinical manifestations of MS are highly variable, but most patients initially experience a relapsing-remitting course. Patients accumulate disability as a result of incomplete recovery from acute exacerbations and/or gradual disease progression. This article briefly reviews the immunopathology of MS, the symptoms and natural course of the disease, and the recently revised MS diagnostic criteria.
12
Relapses and Progression of Disability in Multiple Sclerosis
Christian Confavreux, Sandra Vukusic, Thibault Moreau et al. · New England Journal of Medicine · 2000 · 1.3K citations · Full text
Inflammatory Cortical Demyelination in Early Multiple Sclerosis
Claudia F. Lucchinetti, Bogdan Popescu, Reem F. Bunyan et al. · New England Journal of Medicine · 2011 · 1.1K citations · Full text